Paroxetine hydrochloride

ADVERTISEMENT

Identification

Molecular formula
C19H21ClFN2O3
CAS Number
110429-35-1
IUPAC Name
1-(4-fluorophenyl)-4-[4-(2-methoxyphenyl)piperazin-1-ium-1-yl]butan-1-one;chloride
Molecular Weight
329.82g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.3567g/cm3
Synonyms
Hypnorm
Interesting facts

Interesting Facts about 1-(4-fluorophenyl)-4-[4-(2-methoxyphenyl)piperazin-1-ium-1-yl]butan-1-one;chloride

This compound is an intriguing example of a quaternary ammonium compound that showcases the complex interplay between organic chemistry and pharmacology. Here are some captivating insights:

  • Pharmaceutical Relevance: The structure indicates potential pharmaceutical applications, often linked to the behavior of drugs that target neurotransmitter systems. It may influence serotonin and dopamine pathways, making it a candidate for mood-related disorders.
  • Unique Structure: The presence of both a fluorine atom and a methoxy group allows for a unique interaction with biological targets, which can enhance the compound's potency and selectivity.
  • Piperazine Moiety: The piperazine ring is a well-known scaffold in medicinal chemistry, frequently utilized in the development of antipsychotic and antidepressant medications due to its favorable pharmacological properties.
  • Ionization Behavior: This compound exists as a chloride salt, which impacts its solubility and stability in various conditions, making it easier to handle during synthesis and formulation.
  • Research Interest: Scientists are continuously investigating similar compounds for their ability to modulate receptor activity, exploring their structural-activity relationships (SAR) to optimize efficacy and reduce side effects.

The exploration of such compounds emphasizes the significance of molecular design in developing new therapeutic agents that can target specific biological systems. As chemistry continues to advance, compounds like this one will play a crucial role in shaping future medical treatments.

ADVERTISEMENT